Bringing clinical trials to patients with the decentralized model

Since, COVID-19, which has had a huge impact on global clinical trials, sponsors, CROs, sites, and patients have pivoted to adapt to a more home- or community-based approach. Learn why bringing a trial to a patient’s home – with the help of home healthcare support, telemedicine and sensors, direct-to-patient drug shipments, and more –helps to minimize the barriers to recruitment and retention.

Open PDF

Return to Insights Center